nodes	percent_of_prediction	percent_of_DWPC	metapath
Tazarotene—CYP2C8—Salmeterol—asthma	0.114	0.198	CbGbCtD
Tazarotene—CYP2C8—Mometasone—asthma	0.114	0.198	CbGbCtD
Tazarotene—CYP2C8—Zafirlukast—asthma	0.0898	0.155	CbGbCtD
Tazarotene—CYP2C8—Theophylline—asthma	0.0694	0.12	CbGbCtD
Tazarotene—CYP2C8—Loratadine—asthma	0.0657	0.114	CbGbCtD
Tazarotene—CYP2C8—Montelukast—asthma	0.0657	0.114	CbGbCtD
Tazarotene—CYP2C8—Hydrocortisone—asthma	0.0366	0.0632	CbGbCtD
Tazarotene—CYP2C8—Dexamethasone—asthma	0.0227	0.0393	CbGbCtD
Tazarotene—RARB—respiratory system—asthma	0.00546	0.135	CbGeAlD
Tazarotene—RARB—bronchus—asthma	0.00449	0.111	CbGeAlD
Tazarotene—RARG—respiratory system—asthma	0.00445	0.11	CbGeAlD
Tazarotene—RARA—respiratory system—asthma	0.00418	0.104	CbGeAlD
Tazarotene—RXRB—Vitamin D Metabolism—VDR—asthma	0.00393	0.0377	CbGpPWpGaD
Tazarotene—RARB—adrenal gland—asthma	0.00331	0.082	CbGeAlD
Tazarotene—RXRB—adrenal gland—asthma	0.00304	0.0754	CbGeAlD
Tazarotene—RARB—lung—asthma	0.0029	0.0719	CbGeAlD
Tazarotene—RARG—adrenal gland—asthma	0.0027	0.0669	CbGeAlD
Tazarotene—RXRB—lung—asthma	0.00266	0.0661	CbGeAlD
Tazarotene—RARA—adrenal gland—asthma	0.00253	0.0629	CbGeAlD
Tazarotene—RARG—lung—asthma	0.00236	0.0586	CbGeAlD
Tazarotene—RARA—lung—asthma	0.00222	0.0551	CbGeAlD
Tazarotene—RARG—RXR and RAR heterodimerization with other nuclear receptor—VDR—asthma	0.00213	0.0204	CbGpPWpGaD
Tazarotene—RARG—Nuclear Receptors—ESR2—asthma	0.00198	0.019	CbGpPWpGaD
Tazarotene—RARB—RXR and RAR heterodimerization with other nuclear receptor—VDR—asthma	0.00191	0.0183	CbGpPWpGaD
Tazarotene—RARG—Retinoic acid receptors-mediated signaling—VDR—asthma	0.0019	0.0182	CbGpPWpGaD
Tazarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—VDR—asthma	0.00183	0.0176	CbGpPWpGaD
Tazarotene—RARA—RXR and RAR heterodimerization with other nuclear receptor—VDR—asthma	0.00183	0.0176	CbGpPWpGaD
Tazarotene—RARB—Nuclear Receptors—ESR2—asthma	0.00178	0.017	CbGpPWpGaD
Tazarotene—RXRB—Regulation of Androgen receptor activity—CARM1—asthma	0.00173	0.0166	CbGpPWpGaD
Tazarotene—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—asthma	0.00172	0.0165	CbGpPWpGaD
Tazarotene—RARB—Retinoic acid receptors-mediated signaling—VDR—asthma	0.0017	0.0163	CbGpPWpGaD
Tazarotene—RXRB—Nuclear Receptors—ESR2—asthma	0.0017	0.0163	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptors—ESR2—asthma	0.0017	0.0163	CbGpPWpGaD
Tazarotene—RXRB—Retinoic acid receptors-mediated signaling—VDR—asthma	0.00163	0.0157	CbGpPWpGaD
Tazarotene—RARA—Retinoic acid receptors-mediated signaling—VDR—asthma	0.00163	0.0157	CbGpPWpGaD
Tazarotene—RARG—Nuclear Receptors—VDR—asthma	0.00157	0.0151	CbGpPWpGaD
Tazarotene—RARG—Nuclear Receptor transcription pathway—ESR2—asthma	0.00157	0.015	CbGpPWpGaD
Tazarotene—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—asthma	0.00154	0.0148	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—asthma	0.00148	0.0142	CbGpPWpGaD
Tazarotene—Dermatitis contact—Mometasone—asthma	0.00147	0.00532	CcSEcCtD
Tazarotene—Inflammation—Arformoterol—asthma	0.00144	0.00521	CcSEcCtD
Tazarotene—Inflammation—Formoterol—asthma	0.00144	0.00521	CcSEcCtD
Tazarotene—RARG—Nuclear Receptors—NR3C1—asthma	0.00141	0.0136	CbGpPWpGaD
Tazarotene—RARB—Nuclear Receptors—VDR—asthma	0.00141	0.0135	CbGpPWpGaD
Tazarotene—RARB—Nuclear Receptor transcription pathway—ESR2—asthma	0.0014	0.0135	CbGpPWpGaD
Tazarotene—Dermatitis contact—Arformoterol—asthma	0.00138	0.00499	CcSEcCtD
Tazarotene—Dermatitis contact—Formoterol—asthma	0.00138	0.00499	CcSEcCtD
Tazarotene—Inflammation—Salbutamol—asthma	0.00136	0.00491	CcSEcCtD
Tazarotene—RXRB—Nuclear Receptors—VDR—asthma	0.00135	0.013	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptors—VDR—asthma	0.00135	0.013	CbGpPWpGaD
Tazarotene—RXRB—Nuclear Receptor transcription pathway—ESR2—asthma	0.00135	0.0129	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptor transcription pathway—ESR2—asthma	0.00135	0.0129	CbGpPWpGaD
Tazarotene—Haemoglobin—Zafirlukast—asthma	0.00134	0.00483	CcSEcCtD
Tazarotene—Haemorrhage—Zafirlukast—asthma	0.00133	0.00481	CcSEcCtD
Tazarotene—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—asthma	0.00132	0.0127	CbGpPWpGaD
Tazarotene—Dermatitis bullous—Loratadine—asthma	0.00132	0.00476	CcSEcCtD
Tazarotene—Eczema—Flunisolide—asthma	0.0013	0.00468	CcSEcCtD
Tazarotene—Leukoderma—Prednisone—asthma	0.00129	0.00467	CcSEcCtD
Tazarotene—RARB—Nuclear Receptors—NR3C1—asthma	0.00127	0.0122	CbGpPWpGaD
Tazarotene—Dermatitis contact—Budesonide—asthma	0.00126	0.00456	CcSEcCtD
Tazarotene—Photosensitivity reaction—Cromoglicic acid—asthma	0.00125	0.00454	CcSEcCtD
Tazarotene—RARG—Nuclear Receptor transcription pathway—VDR—asthma	0.00124	0.0119	CbGpPWpGaD
Tazarotene—Skin hyperpigmentation—Hydrocortisone—asthma	0.00124	0.00449	CcSEcCtD
Tazarotene—RARG—RXR and RAR heterodimerization with other nuclear receptor—BCL2—asthma	0.00123	0.0118	CbGpPWpGaD
Tazarotene—RXRB—Nuclear Receptors—NR3C1—asthma	0.00122	0.0117	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptors—NR3C1—asthma	0.00122	0.0117	CbGpPWpGaD
Tazarotene—Haemoglobin—Ciclesonide—asthma	0.00122	0.0044	CcSEcCtD
Tazarotene—RARA—Adipogenesis—MIF—asthma	0.00121	0.0116	CbGpPWpGaD
Tazarotene—Haemorrhage—Ciclesonide—asthma	0.00121	0.00438	CcSEcCtD
Tazarotene—Skin hyperpigmentation—Triamcinolone—asthma	0.00117	0.00423	CcSEcCtD
Tazarotene—Skin hyperpigmentation—Methylprednisolone—asthma	0.00117	0.00422	CcSEcCtD
Tazarotene—Dry skin—Tiotropium—asthma	0.00115	0.00416	CcSEcCtD
Tazarotene—Discomfort—Zileuton—asthma	0.00113	0.0041	CcSEcCtD
Tazarotene—RARG—Nuclear Receptor transcription pathway—NR3C1—asthma	0.00112	0.0107	CbGpPWpGaD
Tazarotene—RARB—Nuclear Receptor transcription pathway—VDR—asthma	0.00111	0.0107	CbGpPWpGaD
Tazarotene—Eczema—Montelukast—asthma	0.0011	0.00399	CcSEcCtD
Tazarotene—RARB—RXR and RAR heterodimerization with other nuclear receptor—BCL2—asthma	0.0011	0.0106	CbGpPWpGaD
Tazarotene—Oedema—Orciprenaline—asthma	0.00107	0.00389	CcSEcCtD
Tazarotene—RXRB—Nuclear Receptor transcription pathway—VDR—asthma	0.00107	0.0102	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptor transcription pathway—VDR—asthma	0.00107	0.0102	CbGpPWpGaD
Tazarotene—Eczema—Salbutamol—asthma	0.00106	0.00385	CcSEcCtD
Tazarotene—Skin hyperpigmentation—Betamethasone—asthma	0.00106	0.00384	CcSEcCtD
Tazarotene—Skin hyperpigmentation—Dexamethasone—asthma	0.00106	0.00384	CcSEcCtD
Tazarotene—RARA—RXR and RAR heterodimerization with other nuclear receptor—BCL2—asthma	0.00106	0.0101	CbGpPWpGaD
Tazarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—BCL2—asthma	0.00106	0.0101	CbGpPWpGaD
Tazarotene—Swelling—Budesonide—asthma	0.00105	0.0038	CcSEcCtD
Tazarotene—Blister—Prednisolone—asthma	0.00105	0.00379	CcSEcCtD
Tazarotene—Oedema—Pirbuterol—asthma	0.00104	0.00378	CcSEcCtD
Tazarotene—Eczema—Budesonide—asthma	0.00103	0.00373	CcSEcCtD
Tazarotene—Haemoglobin—Ipratropium bromide—asthma	0.00101	0.00365	CcSEcCtD
Tazarotene—Haemorrhage—Ipratropium bromide—asthma	0.001	0.00363	CcSEcCtD
Tazarotene—RARB—Nuclear Receptor transcription pathway—NR3C1—asthma	0.001	0.00962	CbGpPWpGaD
Tazarotene—CYP2C8—Arachidonic acid metabolism—LTC4S—asthma	0.000984	0.00944	CbGpPWpGaD
Tazarotene—Discomfort—Zafirlukast—asthma	0.000973	0.00352	CcSEcCtD
Tazarotene—Pain—Ketotifen—asthma	0.00097	0.00351	CcSEcCtD
Tazarotene—Blister—Triamcinolone—asthma	0.000965	0.00349	CcSEcCtD
Tazarotene—RARA—Nuclear Receptor transcription pathway—NR3C1—asthma	0.000961	0.00922	CbGpPWpGaD
Tazarotene—RXRB—Nuclear Receptor transcription pathway—NR3C1—asthma	0.000961	0.00922	CbGpPWpGaD
Tazarotene—Erythema—Cromoglicic acid—asthma	0.000957	0.00346	CcSEcCtD
Tazarotene—Hypertriglyceridaemia—Prednisone—asthma	0.000957	0.00346	CcSEcCtD
Tazarotene—Oedema—Zafirlukast—asthma	0.000944	0.00341	CcSEcCtD
Tazarotene—Pain—Zileuton—asthma	0.00094	0.0034	CcSEcCtD
Tazarotene—RARA—Adipogenesis—STAT6—asthma	0.000936	0.00898	CbGpPWpGaD
Tazarotene—Stinging—Prednisolone—asthma	0.000933	0.00338	CcSEcCtD
Tazarotene—RXRB—Regulation of Androgen receptor activity—NR3C1—asthma	0.000932	0.00895	CbGpPWpGaD
Tazarotene—Dry skin—Arformoterol—asthma	0.000929	0.00336	CcSEcCtD
Tazarotene—Dry skin—Formoterol—asthma	0.000929	0.00336	CcSEcCtD
Tazarotene—Pain—Orciprenaline—asthma	0.000919	0.00332	CcSEcCtD
Tazarotene—Stinging—Hydrocortisone—asthma	0.000911	0.0033	CcSEcCtD
Tazarotene—Pain—Nedocromil—asthma	0.0009	0.00325	CcSEcCtD
Tazarotene—Acne—Prednisolone—asthma	0.000899	0.00325	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—RAD50—asthma	0.000897	0.00861	CbGpPWpGaD
Tazarotene—Acne—Hydrocortisone—asthma	0.000878	0.00317	CcSEcCtD
Tazarotene—Blister—Betamethasone—asthma	0.000875	0.00317	CcSEcCtD
Tazarotene—Blister—Dexamethasone—asthma	0.000875	0.00317	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—RAD50—asthma	0.00086	0.00826	CbGpPWpGaD
Tazarotene—Stinging—Triamcinolone—asthma	0.000858	0.0031	CcSEcCtD
Tazarotene—Oedema peripheral—Tiotropium—asthma	0.000856	0.00309	CcSEcCtD
Tazarotene—CYP2C8—Arachidonic acid metabolism—LTA4H—asthma	0.000853	0.00818	CbGpPWpGaD
Tazarotene—Erythema—Fluticasone Propionate—asthma	0.000846	0.00306	CcSEcCtD
Tazarotene—RARG—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—asthma	0.000844	0.0081	CbGpPWpGaD
Tazarotene—Rash—Terbutaline—asthma	0.000841	0.00304	CcSEcCtD
Tazarotene—Dermatitis—Terbutaline—asthma	0.000841	0.00304	CcSEcCtD
Tazarotene—Blood triglycerides increased—Prednisone—asthma	0.000839	0.00303	CcSEcCtD
Tazarotene—Acne—Triamcinolone—asthma	0.000826	0.00299	CcSEcCtD
Tazarotene—Acne—Methylprednisolone—asthma	0.000824	0.00298	CcSEcCtD
Tazarotene—Skin discolouration—Hydrocortisone—asthma	0.000818	0.00296	CcSEcCtD
Tazarotene—Pain—Zafirlukast—asthma	0.000807	0.00292	CcSEcCtD
Tazarotene—Discomfort—Cromoglicic acid—asthma	0.000805	0.00291	CcSEcCtD
Tazarotene—Pruritus—Ketotifen—asthma	0.000803	0.0029	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—IL1R1—asthma	0.0008	0.00767	CbGpPWpGaD
Tazarotene—Oedema peripheral—Flunisolide—asthma	0.000793	0.00287	CcSEcCtD
Tazarotene—RARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—asthma	0.000788	0.00756	CbGpPWpGaD
Tazarotene—Oedema—Cromoglicic acid—asthma	0.000781	0.00283	CcSEcCtD
Tazarotene—Stinging—Betamethasone—asthma	0.000779	0.00282	CcSEcCtD
Tazarotene—Stinging—Dexamethasone—asthma	0.000779	0.00282	CcSEcCtD
Tazarotene—Pruritus—Zileuton—asthma	0.000778	0.00281	CcSEcCtD
Tazarotene—Pain—Beclomethasone—asthma	0.000768	0.00278	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—IL1R1—asthma	0.000767	0.00736	CbGpPWpGaD
Tazarotene—Pruritus—Indacaterol—asthma	0.000766	0.00277	CcSEcCtD
Tazarotene—Inflammation—Hydrocortisone—asthma	0.000761	0.00275	CcSEcCtD
Tazarotene—Pruritus—Orciprenaline—asthma	0.00076	0.00275	CcSEcCtD
Tazarotene—RARB—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—asthma	0.000757	0.00727	CbGpPWpGaD
Tazarotene—Acne—Betamethasone—asthma	0.00075	0.00271	CcSEcCtD
Tazarotene—Acne—Dexamethasone—asthma	0.00075	0.00271	CcSEcCtD
Tazarotene—Pruritus—Pirbuterol—asthma	0.000739	0.00267	CcSEcCtD
Tazarotene—Dermatitis contact—Hydrocortisone—asthma	0.00073	0.00264	CcSEcCtD
Tazarotene—RARA—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—asthma	0.000726	0.00697	CbGpPWpGaD
Tazarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—asthma	0.000726	0.00697	CbGpPWpGaD
Tazarotene—Rash—Ketotifen—asthma	0.000715	0.00259	CcSEcCtD
Tazarotene—Inflammation—Methylprednisolone—asthma	0.000715	0.00259	CcSEcCtD
Tazarotene—Dermatitis—Ketotifen—asthma	0.000715	0.00259	CcSEcCtD
Tazarotene—Oedema—Ipratropium bromide—asthma	0.000714	0.00258	CcSEcCtD
Tazarotene—Discomfort—Fluticasone Propionate—asthma	0.000712	0.00257	CcSEcCtD
Tazarotene—Discomfort—Salmeterol—asthma	0.00071	0.00257	CcSEcCtD
Tazarotene—RARA—Adipogenesis—GATA3—asthma	0.000709	0.0068	CbGpPWpGaD
Tazarotene—RARB—RXR and RAR heterodimerization with other nuclear receptor—TNF—asthma	0.000707	0.00678	CbGpPWpGaD
Tazarotene—Skin exfoliation—Hydrocortisone—asthma	0.000705	0.00255	CcSEcCtD
Tazarotene—Rash—Zileuton—asthma	0.000693	0.00251	CcSEcCtD
Tazarotene—Dermatitis—Zileuton—asthma	0.000692	0.0025	CcSEcCtD
Tazarotene—Oedema—Fluticasone Propionate—asthma	0.000691	0.0025	CcSEcCtD
Tazarotene—Oedema peripheral—Arformoterol—asthma	0.000691	0.0025	CcSEcCtD
Tazarotene—Oedema peripheral—Formoterol—asthma	0.000691	0.0025	CcSEcCtD
Tazarotene—Oedema—Salmeterol—asthma	0.000689	0.00249	CcSEcCtD
Tazarotene—Dermatitis contact—Triamcinolone—asthma	0.000687	0.00249	CcSEcCtD
Tazarotene—Rash—Indacaterol—asthma	0.000683	0.00247	CcSEcCtD
Tazarotene—Dermatitis—Indacaterol—asthma	0.000682	0.00247	CcSEcCtD
Tazarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TNF—asthma	0.000678	0.0065	CbGpPWpGaD
Tazarotene—RARA—RXR and RAR heterodimerization with other nuclear receptor—TNF—asthma	0.000678	0.0065	CbGpPWpGaD
Tazarotene—Pain—Cromoglicic acid—asthma	0.000668	0.00242	CcSEcCtD
Tazarotene—Pruritus—Zafirlukast—asthma	0.000668	0.00242	CcSEcCtD
Tazarotene—Haemoglobin—Salbutamol—asthma	0.000665	0.00241	CcSEcCtD
Tazarotene—Skin exfoliation—Triamcinolone—asthma	0.000664	0.0024	CcSEcCtD
Tazarotene—Rash—Nedocromil—asthma	0.000663	0.0024	CcSEcCtD
Tazarotene—Dermatitis—Nedocromil—asthma	0.000663	0.0024	CcSEcCtD
Tazarotene—Skin exfoliation—Methylprednisolone—asthma	0.000662	0.0024	CcSEcCtD
Tazarotene—Haemorrhage—Salbutamol—asthma	0.000662	0.00239	CcSEcCtD
Tazarotene—Rash—Pirbuterol—asthma	0.000659	0.00238	CcSEcCtD
Tazarotene—Dermatitis—Pirbuterol—asthma	0.000658	0.00238	CcSEcCtD
Tazarotene—Acne—Prednisone—asthma	0.000653	0.00236	CcSEcCtD
Tazarotene—Haemoglobin—Budesonide—asthma	0.000644	0.00233	CcSEcCtD
Tazarotene—Haemorrhage—Budesonide—asthma	0.000641	0.00232	CcSEcCtD
Tazarotene—Discomfort—Loratadine—asthma	0.000637	0.0023	CcSEcCtD
Tazarotene—Pruritus—Theophylline—asthma	0.000636	0.0023	CcSEcCtD
Tazarotene—Rash—Fluticasone furoate—asthma	0.000634	0.00229	CcSEcCtD
Tazarotene—Dermatitis—Fluticasone furoate—asthma	0.000633	0.00229	CcSEcCtD
Tazarotene—Oedema peripheral—Budesonide—asthma	0.000632	0.00228	CcSEcCtD
Tazarotene—Dermatitis contact—Betamethasone—asthma	0.000623	0.00225	CcSEcCtD
Tazarotene—Dermatitis contact—Dexamethasone—asthma	0.000623	0.00225	CcSEcCtD
Tazarotene—Oedema—Tiotropium—asthma	0.000617	0.00223	CcSEcCtD
Tazarotene—Pain—Ipratropium bromide—asthma	0.00061	0.00221	CcSEcCtD
Tazarotene—Skin exfoliation—Betamethasone—asthma	0.000602	0.00218	CcSEcCtD
Tazarotene—Skin exfoliation—Dexamethasone—asthma	0.000602	0.00218	CcSEcCtD
Tazarotene—Eczema—Hydrocortisone—asthma	0.000596	0.00216	CcSEcCtD
Tazarotene—CYP2C8—Metapathway biotransformation—HNMT—asthma	0.000596	0.00572	CbGpPWpGaD
Tazarotene—Rash—Zafirlukast—asthma	0.000595	0.00215	CcSEcCtD
Tazarotene—Dermatitis—Zafirlukast—asthma	0.000595	0.00215	CcSEcCtD
Tazarotene—Pain—Fluticasone Propionate—asthma	0.000591	0.00214	CcSEcCtD
Tazarotene—Discomfort—Flunisolide—asthma	0.00059	0.00213	CcSEcCtD
Tazarotene—Pain—Salmeterol—asthma	0.000589	0.00213	CcSEcCtD
Tazarotene—Dermatitis bullous—Prednisolone—asthma	0.000574	0.00208	CcSEcCtD
Tazarotene—Oedema—Flunisolide—asthma	0.000572	0.00207	CcSEcCtD
Tazarotene—Rash—Theophylline—asthma	0.000567	0.00205	CcSEcCtD
Tazarotene—Rash—Beclomethasone—asthma	0.000567	0.00205	CcSEcCtD
Tazarotene—Dermatitis—Theophylline—asthma	0.000566	0.00205	CcSEcCtD
Tazarotene—Dermatitis—Beclomethasone—asthma	0.000566	0.00205	CcSEcCtD
Tazarotene—Rash—Ciclesonide—asthma	0.000542	0.00196	CcSEcCtD
Tazarotene—Dermatitis—Ciclesonide—asthma	0.000542	0.00196	CcSEcCtD
Tazarotene—CYP2C8—Arachidonic acid metabolism—ALOX5AP—asthma	0.000536	0.00514	CbGpPWpGaD
Tazarotene—CYP2C8—Arachidonic acid metabolism—ALOX15—asthma	0.000536	0.00514	CbGpPWpGaD
Tazarotene—Pain—Loratadine—asthma	0.000529	0.00191	CcSEcCtD
Tazarotene—Dermatitis bullous—Triamcinolone—asthma	0.000528	0.00191	CcSEcCtD
Tazarotene—Skin exfoliation—Prednisone—asthma	0.000525	0.0019	CcSEcCtD
Tazarotene—Discomfort—Arformoterol—asthma	0.000513	0.00186	CcSEcCtD
Tazarotene—Discomfort—Formoterol—asthma	0.000513	0.00186	CcSEcCtD
Tazarotene—Pruritus—Ipratropium bromide—asthma	0.000505	0.00183	CcSEcCtD
Tazarotene—Dry skin—Prednisolone—asthma	0.000503	0.00182	CcSEcCtD
Tazarotene—Oedema—Arformoterol—asthma	0.000498	0.0018	CcSEcCtD
Tazarotene—Oedema—Formoterol—asthma	0.000498	0.0018	CcSEcCtD
Tazarotene—Rash—Cromoglicic acid—asthma	0.000493	0.00178	CcSEcCtD
Tazarotene—Dermatitis—Cromoglicic acid—asthma	0.000492	0.00178	CcSEcCtD
Tazarotene—Dry skin—Hydrocortisone—asthma	0.000491	0.00178	CcSEcCtD
Tazarotene—Pain—Flunisolide—asthma	0.000489	0.00177	CcSEcCtD
Tazarotene—Pruritus—Fluticasone Propionate—asthma	0.000489	0.00177	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—ESR2—asthma	0.000488	0.00468	CbGpPWpGaD
Tazarotene—Oedema—Montelukast—asthma	0.000488	0.00176	CcSEcCtD
Tazarotene—Discomfort—Salbutamol—asthma	0.000485	0.00175	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—IL3—asthma	0.00048	0.0046	CbGpPWpGaD
Tazarotene—Dermatitis bullous—Dexamethasone—asthma	0.000479	0.00173	CcSEcCtD
Tazarotene—Dermatitis bullous—Betamethasone—asthma	0.000479	0.00173	CcSEcCtD
Tazarotene—RARA—Adipogenesis—SMAD3—asthma	0.000473	0.00454	CbGpPWpGaD
Tazarotene—Oedema—Salbutamol—asthma	0.00047	0.0017	CcSEcCtD
Tazarotene—Discomfort—Budesonide—asthma	0.00047	0.0017	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—ESR2—asthma	0.000468	0.00449	CbGpPWpGaD
Tazarotene—Pruritus—Aminophylline—asthma	0.000463	0.00167	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—IL3—asthma	0.00046	0.00441	CbGpPWpGaD
Tazarotene—RXRB—a6b1 and a6b4 Integrin signaling—EGFR—asthma	0.000459	0.0044	CbGpPWpGaD
Tazarotene—CYP2C8—Arachidonic acid metabolism—ALOX5—asthma	0.000455	0.00437	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—NR3C1—asthma	0.000455	0.00436	CbGpPWpGaD
Tazarotene—Pain—Mometasone—asthma	0.000454	0.00164	CcSEcCtD
Tazarotene—Rash—Ipratropium bromide—asthma	0.00045	0.00163	CcSEcCtD
Tazarotene—Dermatitis—Ipratropium bromide—asthma	0.00045	0.00163	CcSEcCtD
Tazarotene—Pruritus—Tiotropium—asthma	0.000437	0.00158	CcSEcCtD
Tazarotene—Rash—Fluticasone Propionate—asthma	0.000436	0.00158	CcSEcCtD
Tazarotene—Dermatitis—Fluticasone Propionate—asthma	0.000435	0.00157	CcSEcCtD
Tazarotene—Rash—Salmeterol—asthma	0.000435	0.00157	CcSEcCtD
Tazarotene—Dermatitis—Salmeterol—asthma	0.000434	0.00157	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—NTRK1—asthma	0.000431	0.00414	CbGpPWpGaD
Tazarotene—Pain—Formoterol—asthma	0.000426	0.00154	CcSEcCtD
Tazarotene—Pain—Arformoterol—asthma	0.000426	0.00154	CcSEcCtD
Tazarotene—Dry skin—Dexamethasone—asthma	0.00042	0.00152	CcSEcCtD
Tazarotene—Dry skin—Betamethasone—asthma	0.00042	0.00152	CcSEcCtD
Tazarotene—Pain—Montelukast—asthma	0.000417	0.00151	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—NTRK1—asthma	0.000413	0.00397	CbGpPWpGaD
Tazarotene—Rash—Aminophylline—asthma	0.000413	0.00149	CcSEcCtD
Tazarotene—Dermatitis—Aminophylline—asthma	0.000412	0.00149	CcSEcCtD
Tazarotene—Pruritus—Flunisolide—asthma	0.000405	0.00146	CcSEcCtD
Tazarotene—RARA—Adipogenesis—LEP—asthma	0.000404	0.00388	CbGpPWpGaD
Tazarotene—Pain—Salbutamol—asthma	0.000402	0.00145	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—BDNF—asthma	0.000395	0.00379	CbGpPWpGaD
Tazarotene—Rash—Loratadine—asthma	0.00039	0.00141	CcSEcCtD
Tazarotene—Pain—Budesonide—asthma	0.00039	0.00141	CcSEcCtD
Tazarotene—Dermatitis—Loratadine—asthma	0.00039	0.00141	CcSEcCtD
Tazarotene—Rash—Tiotropium—asthma	0.000389	0.00141	CcSEcCtD
Tazarotene—Dermatitis—Tiotropium—asthma	0.000389	0.00141	CcSEcCtD
Tazarotene—Haemoglobin—Prednisolone—asthma	0.000382	0.00138	CcSEcCtD
Tazarotene—Haemorrhage—Prednisolone—asthma	0.00038	0.00137	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—BDNF—asthma	0.000378	0.00363	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—PLA2G4A—asthma	0.000377	0.00362	CbGpPWpGaD
Tazarotene—Pruritus—Mometasone—asthma	0.000375	0.00136	CcSEcCtD
Tazarotene—Haemoglobin—Hydrocortisone—asthma	0.000373	0.00135	CcSEcCtD
Tazarotene—Haemorrhage—Hydrocortisone—asthma	0.000371	0.00134	CcSEcCtD
Tazarotene—Dry skin—Prednisone—asthma	0.000366	0.00132	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—PLA2G4A—asthma	0.000361	0.00347	CbGpPWpGaD
Tazarotene—Rash—Flunisolide—asthma	0.000361	0.0013	CcSEcCtD
Tazarotene—Dermatitis—Flunisolide—asthma	0.00036	0.0013	CcSEcCtD
Tazarotene—RARG—Generic Transcription Pathway—CARM1—asthma	0.000359	0.00345	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—PRMT5—asthma	0.000354	0.0034	CbGpPWpGaD
Tazarotene—Pruritus—Formoterol—asthma	0.000352	0.00127	CcSEcCtD
Tazarotene—Pruritus—Arformoterol—asthma	0.000352	0.00127	CcSEcCtD
Tazarotene—Haemoglobin—Triamcinolone—asthma	0.000351	0.00127	CcSEcCtD
Tazarotene—Haemoglobin—Methylprednisolone—asthma	0.00035	0.00127	CcSEcCtD
Tazarotene—Haemorrhage—Triamcinolone—asthma	0.000349	0.00126	CcSEcCtD
Tazarotene—Haemorrhage—Methylprednisolone—asthma	0.000348	0.00126	CcSEcCtD
Tazarotene—Pruritus—Montelukast—asthma	0.000345	0.00125	CcSEcCtD
Tazarotene—Rash—Mometasone—asthma	0.000335	0.00121	CcSEcCtD
Tazarotene—Dermatitis—Mometasone—asthma	0.000334	0.00121	CcSEcCtD
Tazarotene—Pruritus—Salbutamol—asthma	0.000333	0.0012	CcSEcCtD
Tazarotene—Erythema—Prednisolone—asthma	0.000331	0.0012	CcSEcCtD
Tazarotene—Erythema—Hydrocortisone—asthma	0.000323	0.00117	CcSEcCtD
Tazarotene—Pruritus—Budesonide—asthma	0.000322	0.00117	CcSEcCtD
Tazarotene—RARB—Generic Transcription Pathway—CARM1—asthma	0.000322	0.00309	CbGpPWpGaD
Tazarotene—Haemoglobin—Betamethasone—asthma	0.000318	0.00115	CcSEcCtD
Tazarotene—Haemoglobin—Dexamethasone—asthma	0.000318	0.00115	CcSEcCtD
Tazarotene—RARB—Gene Expression—PRMT5—asthma	0.000318	0.00305	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—SERPINE1—asthma	0.000317	0.00304	CbGpPWpGaD
Tazarotene—Haemorrhage—Betamethasone—asthma	0.000317	0.00115	CcSEcCtD
Tazarotene—Haemorrhage—Dexamethasone—asthma	0.000317	0.00115	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—CDK2—asthma	0.000315	0.00302	CbGpPWpGaD
Tazarotene—Rash—Formoterol—asthma	0.000314	0.00114	CcSEcCtD
Tazarotene—Rash—Arformoterol—asthma	0.000314	0.00114	CcSEcCtD
Tazarotene—Dermatitis—Arformoterol—asthma	0.000314	0.00113	CcSEcCtD
Tazarotene—Dermatitis—Formoterol—asthma	0.000314	0.00113	CcSEcCtD
Tazarotene—RXRB—Generic Transcription Pathway—CARM1—asthma	0.000309	0.00296	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—CARM1—asthma	0.000309	0.00296	CbGpPWpGaD
Tazarotene—Rash—Montelukast—asthma	0.000308	0.00111	CcSEcCtD
Tazarotene—Dermatitis—Montelukast—asthma	0.000307	0.00111	CcSEcCtD
Tazarotene—RARA—Gene Expression—PRMT5—asthma	0.000305	0.00292	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—PRMT5—asthma	0.000305	0.00292	CbGpPWpGaD
Tazarotene—Erythema—Triamcinolone—asthma	0.000304	0.0011	CcSEcCtD
Tazarotene—Erythema—Methylprednisolone—asthma	0.000303	0.0011	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—CDK2—asthma	0.000302	0.00289	CbGpPWpGaD
Tazarotene—Rash—Salbutamol—asthma	0.000297	0.00107	CcSEcCtD
Tazarotene—Dermatitis—Salbutamol—asthma	0.000296	0.00107	CcSEcCtD
Tazarotene—CYP2C8—Phase 1 - Functionalization of compounds—ALDH2—asthma	0.000292	0.0028	CbGpPWpGaD
Tazarotene—Rash—Budesonide—asthma	0.000287	0.00104	CcSEcCtD
Tazarotene—Dermatitis—Budesonide—asthma	0.000287	0.00104	CcSEcCtD
Tazarotene—RARG—Generic Transcription Pathway—PARP1—asthma	0.000285	0.00274	CbGpPWpGaD
Tazarotene—Discomfort—Prednisolone—asthma	0.000278	0.00101	CcSEcCtD
Tazarotene—Haemoglobin—Prednisone—asthma	0.000277	0.001	CcSEcCtD
Tazarotene—Haemorrhage—Prednisone—asthma	0.000276	0.000998	CcSEcCtD
Tazarotene—Erythema—Betamethasone—asthma	0.000276	0.000997	CcSEcCtD
Tazarotene—Erythema—Dexamethasone—asthma	0.000276	0.000997	CcSEcCtD
Tazarotene—Discomfort—Hydrocortisone—asthma	0.000272	0.000982	CcSEcCtD
Tazarotene—RARG—Generic Transcription Pathway—ESR2—asthma	0.00027	0.00259	CbGpPWpGaD
Tazarotene—Oedema—Prednisolone—asthma	0.00027	0.000976	CcSEcCtD
Tazarotene—Oedema—Hydrocortisone—asthma	0.000263	0.000953	CcSEcCtD
Tazarotene—RARB—Generic Transcription Pathway—PARP1—asthma	0.000256	0.00246	CbGpPWpGaD
Tazarotene—Discomfort—Triamcinolone—asthma	0.000256	0.000925	CcSEcCtD
Tazarotene—Discomfort—Methylprednisolone—asthma	0.000255	0.000923	CcSEcCtD
Tazarotene—CYP2C8—Arachidonic acid metabolism—PLA2G4A—asthma	0.000252	0.00242	CbGpPWpGaD
Tazarotene—Oedema—Triamcinolone—asthma	0.000248	0.000897	CcSEcCtD
Tazarotene—RXRB—Generic Transcription Pathway—PARP1—asthma	0.000245	0.00236	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—PARP1—asthma	0.000245	0.00236	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—ESR2—asthma	0.000242	0.00233	CbGpPWpGaD
Tazarotene—Erythema—Prednisone—asthma	0.00024	0.000869	CcSEcCtD
Tazarotene—RXRB—Generic Transcription Pathway—ESR2—asthma	0.000232	0.00223	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—ESR2—asthma	0.000232	0.00223	CbGpPWpGaD
Tazarotene—Discomfort—Betamethasone—asthma	0.000232	0.000839	CcSEcCtD
Tazarotene—Discomfort—Dexamethasone—asthma	0.000232	0.000839	CcSEcCtD
Tazarotene—Pain—Prednisolone—asthma	0.000231	0.000834	CcSEcCtD
Tazarotene—Pain—Hydrocortisone—asthma	0.000225	0.000815	CcSEcCtD
Tazarotene—Oedema—Betamethasone—asthma	0.000225	0.000814	CcSEcCtD
Tazarotene—Oedema—Dexamethasone—asthma	0.000225	0.000814	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—BCL2—asthma	0.000224	0.00215	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—STAT3—asthma	0.000216	0.00207	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—VDR—asthma	0.000215	0.00206	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—BCL2—asthma	0.000214	0.00206	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—PTGS2—asthma	0.000212	0.00204	CbGpPWpGaD
Tazarotene—Pain—Triamcinolone—asthma	0.000212	0.000767	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—PTGS2—asthma	0.000204	0.00195	CbGpPWpGaD
Tazarotene—Discomfort—Prednisone—asthma	0.000202	0.000731	CcSEcCtD
Tazarotene—RARG—Generic Transcription Pathway—SMAD3—asthma	0.000201	0.00193	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—TGFB1—asthma	0.0002	0.00192	CbGpPWpGaD
Tazarotene—Oedema—Prednisone—asthma	0.000196	0.000709	CcSEcCtD
Tazarotene—RARG—Generic Transcription Pathway—NR3C1—asthma	0.000193	0.00185	CbGpPWpGaD
Tazarotene—Pain—Dexamethasone—asthma	0.000192	0.000696	CcSEcCtD
Tazarotene—Pain—Betamethasone—asthma	0.000192	0.000696	CcSEcCtD
Tazarotene—RARB—Generic Transcription Pathway—VDR—asthma	0.000192	0.00185	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—TNF—asthma	0.000187	0.00179	CbGpPWpGaD
Tazarotene—Pruritus—Hydrocortisone—asthma	0.000186	0.000674	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—PTEN—asthma	0.000185	0.00178	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—VDR—asthma	0.000185	0.00177	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—VDR—asthma	0.000185	0.00177	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—SMAD3—asthma	0.00018	0.00173	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—PTEN—asthma	0.000178	0.0017	CbGpPWpGaD
Tazarotene—Pruritus—Triamcinolone—asthma	0.000176	0.000635	CcSEcCtD
Tazarotene—Pruritus—Methylprednisolone—asthma	0.000175	0.000633	CcSEcCtD
Tazarotene—RARB—Generic Transcription Pathway—NR3C1—asthma	0.000173	0.00166	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—CARM1—asthma	0.000173	0.00166	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—SMAD3—asthma	0.000173	0.00166	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—SMAD3—asthma	0.000173	0.00166	CbGpPWpGaD
Tazarotene—Rash—Prednisolone—asthma	0.00017	0.000615	CcSEcCtD
Tazarotene—Dermatitis—Prednisolone—asthma	0.00017	0.000615	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—VEGFA—asthma	0.000167	0.00161	CbGpPWpGaD
Tazarotene—Rash—Hydrocortisone—asthma	0.000166	0.000601	CcSEcCtD
Tazarotene—RARA—Generic Transcription Pathway—NR3C1—asthma	0.000166	0.00159	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—NR3C1—asthma	0.000166	0.00159	CbGpPWpGaD
Tazarotene—Dermatitis—Hydrocortisone—asthma	0.000166	0.0006	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—VEGFA—asthma	0.00016	0.00154	CbGpPWpGaD
Tazarotene—Pruritus—Betamethasone—asthma	0.000159	0.000576	CcSEcCtD
Tazarotene—Pruritus—Dexamethasone—asthma	0.000159	0.000576	CcSEcCtD
Tazarotene—Rash—Triamcinolone—asthma	0.000156	0.000566	CcSEcCtD
Tazarotene—Dermatitis—Triamcinolone—asthma	0.000156	0.000565	CcSEcCtD
Tazarotene—Rash—Methylprednisolone—asthma	0.000156	0.000564	CcSEcCtD
Tazarotene—Dermatitis—Methylprednisolone—asthma	0.000156	0.000564	CcSEcCtD
Tazarotene—RARB—Gene Expression—CARM1—asthma	0.000155	0.00149	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—ALDH2—asthma	0.000155	0.00149	CbGpPWpGaD
Tazarotene—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—asthma	0.000154	0.00148	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—TGFB1—asthma	0.000154	0.00147	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—IL6—asthma	0.000151	0.00145	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—EGFR—asthma	0.000151	0.00145	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—CARM1—asthma	0.000149	0.00143	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—CARM1—asthma	0.000149	0.00143	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—GSTT1—asthma	0.000147	0.00141	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—TGFB1—asthma	0.000147	0.00141	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—DNMT1—asthma	0.000145	0.00139	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—EGFR—asthma	0.000144	0.00139	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—TNF—asthma	0.000143	0.00138	CbGpPWpGaD
Tazarotene—CYP2C8—Arachidonic acid metabolism—PTGS2—asthma	0.000142	0.00137	CbGpPWpGaD
Tazarotene—Rash—Dexamethasone—asthma	0.000142	0.000513	CcSEcCtD
Tazarotene—Rash—Betamethasone—asthma	0.000142	0.000513	CcSEcCtD
Tazarotene—Dermatitis—Betamethasone—asthma	0.000142	0.000513	CcSEcCtD
Tazarotene—Dermatitis—Dexamethasone—asthma	0.000142	0.000513	CcSEcCtD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—LTC4S—asthma	0.000141	0.00135	CbGpPWpGaD
Tazarotene—Pruritus—Prednisone—asthma	0.000139	0.000502	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—TNF—asthma	0.000138	0.00132	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—PARP1—asthma	0.000137	0.00132	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—SERPINE1—asthma	0.000135	0.00129	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—ESR2—asthma	0.00013	0.00125	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—DNMT1—asthma	0.00013	0.00125	CbGpPWpGaD
Tazarotene—CYP2C8—Phase 1 - Functionalization of compounds—POMC—asthma	0.000125	0.0012	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—DNMT1—asthma	0.000125	0.0012	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—DNMT1—asthma	0.000125	0.0012	CbGpPWpGaD
Tazarotene—Rash—Prednisone—asthma	0.000124	0.000447	CcSEcCtD
Tazarotene—Dermatitis—Prednisone—asthma	0.000123	0.000447	CcSEcCtD
Tazarotene—RARB—Gene Expression—PARP1—asthma	0.000123	0.00118	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—LTA4H—asthma	0.000122	0.00117	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—SERPINE1—asthma	0.000121	0.00116	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—PARP1—asthma	0.000118	0.00113	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—PARP1—asthma	0.000118	0.00113	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—ESR2—asthma	0.000117	0.00112	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—SERPINE1—asthma	0.000116	0.00111	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—SERPINE1—asthma	0.000116	0.00111	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—ESR2—asthma	0.000112	0.00107	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—ESR2—asthma	0.000112	0.00107	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—VDR—asthma	0.000103	0.000991	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—GSTP1—asthma	0.000102	0.000981	CbGpPWpGaD
Tazarotene—CYP2C8—Metapathway biotransformation—GSTP1—asthma	0.000101	0.000967	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—SMAD3—asthma	9.67e-05	0.000928	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—GSTM1—asthma	9.39e-05	0.000901	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—NR3C1—asthma	9.3e-05	0.000892	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—VDR—asthma	9.27e-05	0.000889	CbGpPWpGaD
Tazarotene—CYP2C8—Metapathway biotransformation—GSTM1—asthma	9.26e-05	0.000889	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—PPP2CA—asthma	9.25e-05	0.000888	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—VDR—asthma	8.88e-05	0.000852	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—VDR—asthma	8.88e-05	0.000852	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—SMAD3—asthma	8.68e-05	0.000832	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—NR3C1—asthma	8.34e-05	0.0008	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—SMAD3—asthma	8.32e-05	0.000798	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—SMAD3—asthma	8.32e-05	0.000798	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—PPP2CA—asthma	8.3e-05	0.000796	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—NR3C1—asthma	8e-05	0.000767	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—NR3C1—asthma	8e-05	0.000767	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—PPP2CA—asthma	7.96e-05	0.000764	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—PPP2CA—asthma	7.96e-05	0.000764	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—ALOX5AP—asthma	7.66e-05	0.000735	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—ALOX15—asthma	7.66e-05	0.000735	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—asthma	7.3e-05	0.000701	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—POMC—asthma	6.64e-05	0.000637	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—ALOX5—asthma	6.51e-05	0.000625	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—SERPINE1—asthma	6.49e-05	0.000622	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—LTC4S—asthma	6.26e-05	0.000601	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—asthma	6.21e-05	0.000596	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—SERPINE1—asthma	5.82e-05	0.000558	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—SERPINE1—asthma	5.58e-05	0.000535	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—SERPINE1—asthma	5.58e-05	0.000535	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—LTA4H—asthma	5.43e-05	0.000521	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ARG1—asthma	4.75e-05	0.000455	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ALDH7A1—asthma	4.29e-05	0.000412	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ARG2—asthma	4.11e-05	0.000395	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	3.61e-05	0.000346	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ALOX5AP—asthma	3.41e-05	0.000327	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ALOX15—asthma	3.41e-05	0.000327	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CHAT—asthma	3.25e-05	0.000312	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ALOX5—asthma	2.9e-05	0.000278	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CARM1—asthma	2.77e-05	0.000265	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—DCN—asthma	2.73e-05	0.000262	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ALDH2—asthma	2.65e-05	0.000254	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—POMC—asthma	2.55e-05	0.000245	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GSTT1—asthma	2.52e-05	0.000242	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—ALB—asthma	2.32e-05	0.000223	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—NQO1—asthma	2.1e-05	0.000201	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ADCY2—asthma	2.05e-05	0.000197	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—asthma	2.03e-05	0.000195	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—asthma	1.77e-05	0.00017	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GSTP1—asthma	1.75e-05	0.000168	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—HMOX1—asthma	1.72e-05	0.000165	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ITPR1—asthma	1.72e-05	0.000165	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CAT—asthma	1.7e-05	0.000163	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PLA2G4A—asthma	1.61e-05	0.000154	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GSTM1—asthma	1.61e-05	0.000154	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PPP2CA—asthma	1.48e-05	0.000142	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—POMC—asthma	1.14e-05	0.000109	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ALB—asthma	1.04e-05	9.93e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—NOS3—asthma	9.9e-06	9.5e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PTGS2—asthma	9.06e-06	8.69e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PTEN—asthma	7.9e-06	7.58e-05	CbGpPWpGaD
